ERIS Lifesciences Ltd

ERIS Lifescience | 540596

Live

₹1,431.20

+₹1.14 (+0.08%)

As on 10/07/26, 8:55 PM

Market Cap19,816.73 CR

Current Price₹1,431.2

High / Low₹1,885 / 1,200

PE Ratio54.84

Book Value₹209.57

Dividend Yield0.52%

ROCE13.29%

ROE3.07%

Face Value₹2.00

Current Vol.99,913

Average Vol.---

ISININE406M01024

PB Ratio6.76

Debt to Equity0.97

Net Profit Margin12.88

Operating Margin35.61

Share Price Chart - ERIS Lifesciences Ltd

+₹0.00 (+0.00%)6M

Stock Performance

₹1,430₹1,416.1

₹1,431.2

Previous CloseToday's Open

₹1,200₹1,885

₹1,431.2

52W Low52W High

₹1,416.1Today's Open

₹1,430Previous Close

99,913Volume

₹1,20052W Low

₹1,88552W High

Ratios

No data available

About Company

Eris Lifesciences Limited was incorporated on January 25, 2007
Subsequently, the name of the company was changed to 'Eris Lifesciences Private Limited' on February 9, 2007
Further, the Company was converted into a Public Limited cCompany and the name was changed to 'Eris Lifesciences Limited' on February 2, 2017
The Company has a manufacturing plant in Guwahati, Assam and is presently engaged in manufacturing and marketing of pharmaceutical products
It has presence in high growth chronic, sub chronic and acute therapeutic areas that require high intervention of specialist and super specialist doctors
The company develops, manufactures and commercializes branded pharmaceutical products in selected therapeutic areas within chronic and acute categories of the Indian Pharmaceutical Market (IPM), such as: cardiovascular; anti-diabetics; vitamins; gastroenterology; and anti-infective
Its focus has been on developing products in the chronic and acute categories which are linked to lifestyle related disorders
In 2007, the company launched 'Eris' division focused on cardiology and diabetes segment
In 2008, the company launched 'Nikkos' division focused on gastroenterology and orthopedics segment
In 2009, the company launched 'Adura' division focused on cardiology and diabetes segment

Ethics: ERIS Lifesciences Ltd is flagged for

Animal Cruelty

The company engages directly in some form of animal cruelty through its business.

Adequate

---

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI52.59

SMA 201427.01

SMA 501389.50

SMA 1001374.46

SMA 2001464.02

SMA 101435.49

MACD_12_26_Days13.03

EMA10Day1432.41

EMA20Day1424.01

EMA50Day1403.16

MACD_12_26_9_Days-3.16

EMA100Day1407.91

EMA200Day1438.91

Pivot Points

Volume Analysis

Delivery

Total Volume

Growth Rate

Revenue Growth41.45%

ROE13.77%

EBITDA Margin35.61%

All figures in ₹ Crores

Indicators	2025	2024	2023	2022	2021
Revenue	2,893.64	2,009.15	1,685.15	1,347.04	1,211.86
Interest	231.29	84.80	26.17	4.15	1.80
Expenses	1,876.44	1,334.32	1,148.40	862.09	781.29
Financing Profit	1,035.62	698.65	547.90	511.05	439.28
Financing Margin %	36%	35%	33%	38%	36%
Other Income	18.42	23.82	11.15	26.09	8.71
Depreciation	315.46	182.51	117.09	64.71	42.99
Profit before tax	488.87	431.34	404.64	442.20	394.50
Tax %	23%	8%	8%	8%	10%
Net Profit	374.67	397.12	374.16	405.79	355.13
EPS in Rs	25.85	28.82	28.10	29.89	26.16

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

Deal	Date	Type	Quantity	Price	Traded %
INFINITY PARTNERS	22 Aug ‘24	Purchase	98,86,882	₹1,201	3189.01%
EMERALD INVESTMENTS LIMITED	22 Aug ‘24	Sell	98,86,882	₹1,201	3189.01%
HDFC MUTUAL FUND	06 Jul ‘23	Purchase	6,75,000	₹697	716.68%
HDFC MUTUAL FUND	06 Jul ‘23	Purchase	13,50,000	₹697	1433.36%
SHAH RAKESH	06 Jul ‘23	Sell	27,00,000	₹697	2866.73%
BAKSHI AMIT INDUBHUSAN	30 Jun ‘23	Purchase	28,00,000	₹680	803.38%
SHAH RAKESH	30 Jun ‘23	Sell	28,00,000	₹680	803.38%

News

📊

No Information Available

No news available for this company.

Record Date

Corporate Action

Information

Announcement Day

29 May 2026

Interim Dividend (₹7.21)

Declaration of interim dividend of Rs. 7.21/- (at the rate of 721%) on each fully paid-up equity share of Re. 1/- each for the Financial Year 2026-2027

20 May 2026

25 Jul 2025

AGM

30 Jun 2025

13 Feb 2025

Interim Dividend (₹7.35)

Declaration of interim dividend of Rs. 7.35/- (at the rate of 735%) on each fully paid-up equity share of Re. 1/- for the Financial Year 2024-2025

07 Feb 2025

25 Sept 2024

AGM

04 Sept 2024

25 Sept 2023

AGM

07 Aug 2023

01 Sept 2022

AGM

15 Jun 2022

16 Aug 2022

Interim Dividend (₹7.35)

Eris Lifesciences Ltd has informed BSE that the Board of Directors of the Company, in their meeting held on August 05, 2022, inter alia, approved/took on record the following : Declaration of interim dividend of Rs. 7.35/- (at the rate of 735%) on each fully paid-up equity share of Re. 1/- for the Financial Year 2022-2023.

05 Aug 2022

01 Sept 2021

AGM

29 Jul 2021

06 Aug 2021

Interim Dividend (₹6.01)

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e., July 29, 2021 inter alia, duly approved / took on record the following: Declaration of interim dividend of Rs. 6.01 (at the rate of 601%) on each fully paid-up equity share of Re. 1/- for the Financial Year 2021-2022;

29 Jul 2021

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
1,429	19,799	31	5	22	1	12.88%
1,935	4,64,331	37	6	30	0	19.78%
6,836	1,81,466	69	11	59	0	23.41%
4,903	1,65,952	76	20	50	1	11.09%
1,439	1,16,229	31	3	23	0	9.92%
1,151	1,14,763	21	4	17	0	19.86%
2,496	1,14,128	20	5	16	0	14.56%
2,525	1,04,275	52	6	36	0	14.39%
1,246	1,03,959	26	3	17	0	12.34%
1,565	90,875	26	2	17	0	10.98%

Showing 10 of 134 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in less than 10 mins*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

DIXONDixon Technologies (India) Ltd
₹13,421-56 (-0.42%)

Frequently Asked Questions

What is Share Price of ERIS Lifesciences Ltd?

The current share price of ERIS Lifesciences Ltd (ERIS Lifescience) is ₹1431.20. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of ERIS Lifesciences Ltd?

The Price-to-Earnings (P/E) ratio of ERIS Lifesciences Ltd is 1431.20. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of ERIS Lifesciences Ltd?

ERIS Lifesciences Ltd has a 52-week high of ₹1885.00 and a 52-week low of ₹1200.00. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of ERIS Lifesciences Ltd?

ERIS Lifesciences Ltd offers a dividend yield of 0.50%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of ERIS Lifesciences Ltd?

The Earnings Per Share (EPS) of ERIS Lifesciences Ltd is ₹45.64. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of ERIS Lifesciences Ltd?

ERIS Lifesciences Ltd has a Return on Equity (ROE) of 3.07%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds. Play Video